Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia

R Zittoun, Franco Mandelli, Roel Willemze, +18

New England Journal of Medicine

Erythrocyte Sedimentation Rate Predicts Early Relapse and Survival in Early-Stage Hodgkin Disease

M. Henry‐Amar, Samuel Friedman, Marcel Hayat, +14

Annals of Internal Medicine

The influence of HLA‐matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA

S. Keating, Théo de Witte, Stefan Suciu, +12

British Journal of Haematology

Prognostic factors in advanced nonseminomatous testicular cancer a multivariate logistic regression analysis

Jean Pierre Droz, Marwane Ghosn, G. Piot, +11

Cancer

Prognostic FactorsPrognostic EvaluationUrologyNsgct PatientsAfp Values +10

Prognostic significance of the number of involved areas in the early stages of Hodgkin's disease

Maurice Tubiana, M. Henry‐Amar, Marcel Hayat, +5

Cancer

Relapse PatternsDisease ProgressionImmunodeficienciesPrognosisDiagnosis +20

Mantle Cell Lymphomas: Characteristics, Natural History and Prognostic Factors of 45 Cases

Didier Decaudin, Jacques Bosq, Jean‐Nicolas Munck, +11

Leukemia & lymphoma/Leukemia and lymphoma

Clinical pharmacology of high-dose etoposide associated with cisplatin. Pharmacokinetic and metabolic studies

Alain Gouyette, Anne Deniel, J. L. Pico, +5

European Journal of Cancer and Clinical Oncology

Molecular PharmacologyMetabolic StudiesOncologyMedicineHigh-dose Etoposide +6

High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study

A. Ibrahim, E Zambon, J. H. Bourhis, +9

European Journal of Cancer

Hematological MalignancyTransplantationMarrow TransplantationHealth SciencesMedicine +10

FAILURE OF A CD18/ANTI-LFAl MONOCLONAL ANTIBODY PATIENTS RECEIVING T-DEPLETED ALLOGENEIC BONE INFUSION TO PREVENT GRAFT REJECTION IN LEUKEMIC MARROW TRANSPLANTATION

D Baume, M Kuentz, José-Luis Pico, +4

Transplantation

Cell TherapyImmunologyCommon Beta ChainImmunotherapyEarly Sepsis +16

SERUM LEVELS AND RECEPTOR EXPRESSION OF TUMOR NECROSIS FACTOR-α FOLLOWING HUMAN ALLOGENEIC AND AUTOLOGOUS BONE MARROW TRANSPLANTATION

Éric Robinet, A. Ibrahim, Alemseged Truneh, +7

Transplantation

Transplantation MedicineImmunologyPathologyImmunotherapyInflammation +14